88
Views
2
CrossRef citations to date
0
Altmetric
Case Reports

Ovarian melanoma complicating pregnancy achieved by in-vitro fertilisation

, , , , , & show all
Pages 89-91 | Published online: 21 Dec 2012

References

  • Althuis MD, Scoccia B, Lamb EJ . 2005. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. American Journal of Obstetrics and Gynecology 193:668–674.
  • Brinton LA, Moghissi KS, Scoccia B . 2005. Ovulation induction and cancer risk. Fertility and Sterility 83:261–274.
  • Fuller PN. 1999. Malignant melanoma of the ovary and exposure to clomiphene citrate: a case report and review of the literature. American Journal of Obstetrics and Gynecology 180:1499–1503.
  • Hannibal CG, Jensen A, Sharif H . 2008. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study. Cancer Causes and Control 19:759–765.
  • Jhaveri MB, Driscoll MS, Grant-Kels JM. 2011. Melanoma in pregnancy. Clinical Obstetrics and Gynecology 54:537–545.
  • Kvaskoff M, Bijon A, Mesrine S . 2011. Cutaneous melanoma and endogenous hormonal factors: a large French prospective study. American Journal of Epidemiology 173:1192–1202.
  • MacKie RM, Hauschild A, Eggermont AM. 2009. Epidemiology of invasive cutaneous melanoma. Annals of Oncology 20(Suppl 6):1–7.
  • McCluggage WG, Bissonnette JP, Young RH. 2006. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms. International Journal of Gynecological Pathology 25:321–329.
  • Pentheroudakis G, Orecchia R, Hoekstra HJ . 2010. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 21(Suppl 5):266–273.
  • Yli-Kuha AN, Gissler M, Klemetti R . 2012. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Human Reproduction 27:1149–1155.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.